Track: Multidisciplinary
Keith Gomez, PhD (he/him/his)
Consultant Haematologist
Haemophilia Centre and Thrombosis Unit
Royal Free London NHS Foundation Trust
London, United Kingdom
Mathieu Jackson, MA (he/him/his)
President
Canadian Hemophilia Society, Quebec Chapter
Montreal, Canada
.jpg "Kat Molitor, MSN, RN-BC, AGCNS-BC, CCRC (she/her/hers) photo")
Kat Molitor, MSN, RN-BC, AGCNS-BC, CCRC (she/her/hers)
Clinical Nurse Specialist
Indiana Hemophilia & Thrombosis Center
.jpg "Brian O'Mahony, FACSLM photo")
Brian O'Mahony, FACSLM
CEO
Irish Haemophilia Society
Dublin, Ireland
In an era of new treatments, the way in which consent is discussed and obtained needs to be far wider than it has in the past. In this session we will explore what is legally required to fulfill consent, what an effective consenting process looks like, and why this is critical in the current climate. Join the discussion to hear more from patients undergoing different treatment plans, as well as experts from diverse professions, as they explore the evolving process of consent, and how this conversation needs to widen beyond the patient perspective.
Chair: Keith Gomez, PhD (he/him/his) – Royal Free London NHS Foundation Trust
Speaker: Keith Gomez, PhD (he/him/his) – Royal Free London NHS Foundation Trust
Speaker: Brian O'Mahony, FACSLM – Irish Haemophilia Society
Speaker: Mathieu Jackson, MA (he/him/his) – Canadian Hemophilia Society, Quebec Chapter
Speaker: Kat Molitor, MSN, RN-BC, AGCNS-BC, CCRC (she/her/hers) – Indiana Hemophilia & Thrombosis Center
Chair: Keith Gomez, PhD (he/him/his) – Royal Free London NHS Foundation Trust